DiaMedica Therapeutics Inc. (DMAC)
↓ Download CSV- Sector Manufacturing
- Incorporated Z4
- Fiscal year ends Dec 31
Key ratios (FY2025)
-58.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $500.0K | — | — |
| Operating Income | -$34.40M | -$26.68M | -$21.27M | -$14.00M | -$13.65M | -$12.70M | -$11.59M | -$6.76M | -$4.52M | — |
| Net Income | -$32.77M | -$24.44M | -$19.38M | -$13.68M | -$13.59M | -$12.29M | -$10.65M | -$5.73M | -$4.26M | — |
| EPS (Diluted) | $-0.70 | $-0.60 | $-0.60 | $-0.52 | $-0.65 | — | — | — | — | — |
| Total Assets | $61.37M | $46.34M | $54.16M | $34.40M | $45.55M | $28.09M | $9.05M | $18.34M | $1.80M | — |
| Shareholders' Equity | $56.11M | $40.72M | $51.06M | $31.83M | $44.02M | $26.01M | $7.62M | $17.02M | $799.0K | $1.11M |
| Cash & Equivalents | $15.65M | $3.02M | $4.54M | $4.73M | $4.71M | $7.41M | $3.88M | $16.82M | $1.35M | — |
| Operating Cash Flow | -$29.06M | -$22.08M | -$18.73M | -$11.51M | -$12.25M | -$9.19M | -$9.10M | -$5.70M | -$3.90M | — |
| Capital Expenditures | $40.0K | $25.0K | $24.0K | $81.0K | $22.0K | $47.0K | $2.0K | $50.0K | $22.0K | — |
| Shares Outstanding | 53.74M | 42.82M | 37.96M | 26.44M | 26.44M | 18.75M | 12.01M | 11.96M | 6.37M | — |